Triclabendazole Market (Dosage Form: Tablet and Oral Suspension; Animal Type: Cattle, Sheep, Goat, and Others; and Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The global Triclabendazole market gathered revenue around USD 490 Million in 2021 and market is set to grow USD 632.9 Million by the end of 2030 and is estimated to expand at a modest CAGR of 4.1% during the prediction period 2022 to 2030.

Growth Factors:

Triclabendazole is a well-known anthelmintic flukicide that belongs to the benzimidazole chemical family. It is widely used on sheep, goats, and cattle, primarily as drenches and seldom in tablets, boluses, or other forms. Only triclabendazole is effective against the very early phases of liver fluke infection, from two weeks after infection to adulthood. Triclabendazole is one of the primary controlling measures for eradicating trematode Fasciola hepatica in livestock. Hence, the use of triclabendazole for animals is anticipated to increase during the forecast period, which is expected to boost the growth of the global market.

Report Scope of the Triclabendazole Market

 Increase in Incidence of Faciolas Hepatica (Liver Fluke)

Fasciola hepatica, also known as the common liver fluke, occurs in many areas of the world and is usually caused by F. hepatica. In general, fascioliasis is more common and widespread in animals than in people. In the U.K., fluke prevalence in adult dairy cattle has been reported to be 48% to 76%. Prevalence of F. hepatica has increased in the past few years, and fasciolosis has been reported in new areas, thought to be due to wetter summers and warmer winters.

Factors such as rise in demand for improved nutrition, particularly animal protein, and increase in focus on food safety are likely to boost the demand for triclabendazole medicine over the next few years. The demand for milk and milk products has increased in the past few years, which, in turn, is projected to fuel the growth of the global triclabendazole market during the forecast period. Hence, increase in incidence of Faciolas hepatica or liver fluke is anticipated to propel the global market.

Triclabendazole Market: Key Drivers

Rise in prevalence of liver fluke caused by trematode parasite is anticipated to drive the need of triclabendazole drugs for the treatment of the same

Fasciola hepatica, also known as the common liver fluke, occurs in many areas of the world and usually is caused by F. hepatica. In general, fascioliasis is more common and widespread in animals than in people.

Liver fluke affects sheep and cattle of all ages and can reduce live-weight gains by 10% in adults and 30% in lambs and calves. The weather has a significant effect on the prevalence of liver fluke, especially mild winters and wet summers. The first step toward more effective treatment and control on farms is to gain a better understanding of the infection cycle and seasonal hazards of liver fluke.

A range of products can be used to treat cattle and sheep for fluke. When choosing treatment plans, it is important to use drugs that target the stage most likely to be present within the animal at the time to help reduce selection pressure. Triclabendazole is the only product that is effective against the very early stages, from two weeks after infection to adults.

Market Segmentation: Triclabendazole Market

In terms of dosage form, the global triclabendazole market has been bifurcated into tablet and oral suspension

Based on animal type, the global triclabendazole market has been classified into cattle, sheep, goat, and others

Based on distribution channel, the global triclabendazole market has been divided into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others

Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The triclabendazole market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

North America to Lead Global Triclabendazole Market

In terms of region, the global triclabendazole market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global triclabendazole market in 2020, accounting for 30.9% share, owing to large livestock population, increase in spending on preventive health care, and rise in number of veterinary clinics in the U.S.

Europe held significant share of the global market in 2020, due to presence of several key players in animal health. It is likely to be an attractive market during the forecast period. This can be attributed to large livestock population and rise in prevalence of liver fluke in grazing animals.

Some of the prominent players in the Triclabendazole Market include:  

• AdvaCare Pharma
• RV Lifesciences Limited
• Grampus Laboratories
• Intas Pharmaceuticals Ltd.
• Shanghai Tongren Pharmaceutical Co., Ltd.
• Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd.
• Siflon Drugs & Pharmaceuticals Pvt. Ltd.
• Elanco
• Virbac
• Bimeda, Inc.
• Chanelle Pharma
• Zoetis Health

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Global Triclabendazole Market: Segmentation

• Triclabendazole Market, by Dosage Form
• Tablet
• Oral Suspension
• Triclabendazole Market, by Animal Type
• Cattle
• Sheep
• Goat
• Others
• Triclabendazole Market, by Distribution Channel
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Triclabendazole Market Study:

• Growth of Triclabendazole in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Triclabendazole and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Triclabendazole Consumption Analysis
•  Triclabendazole Production Analysis
•  Triclabendazole and Management